Skip to main content

Jeffrey Mitchell

LexaGene Holdings has appointed Jeffrey Mitchell as its chief financial officer effective immediately. 

Mitchell has more than two decades of financial and SEC experience, LexaGene said. Before joining the firm, he served in positions of increasing responsibility for Palomar Medical Technologies, including controller, director of finance, and supervisor of public-company financial reporting, audits, and financial planning and analysis.

He replaced Zula Kropivnitski.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.